Bacterial carrier status at the time of intervention
| Pathogen | % all patients (n=34) | % patients with FEV1 <40% pred. (n=13) | % non-survivors without lung transplant (n=8) | % patients with lung transplant (n=12) | % patients with reintervention (n=20) |
| Pseudomonas aeruginosa | 79.4 | 92 | 87.5 | 100 | 80 |
| Staphylococcus aureus including MRSA | 50 | 61.5 | 87.5 | 25 | 45 |
| MRSA | 17.6 | 7.7 | 25 | 8.35 | 20 |
| Aspergillus fumigatus | 47.1 | 76.9 | 47.1 | 66.7 | 65 |
| P. aeruginosa and S. aureus | 35.3 | 38.5 | 75 | 25 | 40 |
| Achromobacter xylosoxidans | 26.5 | 38.4 | 50 | 16.7 | 30 |
FEV1% pred., functional end-expiratory volume in 1 s in % predicted; MRSA, methicillin-resistant Staphylococcus aureus.